Thanks to the efforts made by numerous researchers, several classifications have been developed to categorize breast cancers (161, 162), including the immunohistochemical subtype characterized by the expression of estrogen receptors (ER), progesterone (PR) and epidermal growth factor receptor 2 (HER2). Here, ERBB2 is linked to breast cancer.